Radiation Recall Dermatitis With Concomitant Dabrafenib and Pazopanib Therapy
- 1 May 2016
- journal article
- case report
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 152 (5), 587-9
- https://doi.org/10.1001/jamadermatol.2015.5366
Abstract
Case Report from JAMA Dermatology — Radiation Recall Dermatitis With Concomitant Dabrafenib and Pazopanib TherapyKeywords
This publication has 6 references indexed in Scilit:
- Vemurafenib-Induced Radiation Recall Dermatitis: Case Report and Review of the LiteratureDermatology, 2014
- Targeted therapy-induced radiation recallEuropean Journal Of Cancer, 2013
- A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2012
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trialThe Lancet, 2012
- Radiation recall: A well recognized but neglected phenomenonCancer Treatment Reviews, 2005
- Characterizing the phenomenon of radiation recall dermatitisRadiotherapy and Oncology, 2001